Ursprung des Netzwerks ersten Grades von Joseph Lorello
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Massachusetts College of Pharmacy & Health Science
6
| College/University | Other Consumer Services | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Joseph Lorello
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CARDINAL HEALTH, INC. | Medical Distributors | Director/Board Member | |
| CELGENE | Biotechnology | Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TEXAS INSTRUMENTS INCORPORATED | Semiconductors | Director/Board Member | |
| RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Immtech Pharmaceuticals, Inc.
 Immtech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immtech Pharmaceuticals, Inc. develops and distributes pharmaceuticals. The company's efforts reflect extensive work in clinical research, new product development and marketing. The company focuses on developing a new treatment for the Hepatitis C virus. Immtech Pharmaceuticals was founded on October 15, 1984 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chairman | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Humacyte Global, Inc.
 Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Medical Specialties | Chief Executive Officer | |
Renetx Bio, Inc.
 Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member | |
Artax Biopharma, Inc.
 Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Executive Officer | |
| Boston College | College/University | Undergraduate Degree | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree | |
| MEDIVATION INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Corporate Officer/Principal | |
| Wyeth-Ayerst Research | Corporate Officer/Principal | ||
| HAYAT PHARMACEUTICAL INDUSTRIES CO. PLC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Premium Brands Jordan
 Premium Brands Jordan Specialty StoresRetail Trade Premium Brands Jordan provides food and non-food distribution services. It distributes a range of international and regional brands. The company was founded in 1930 and is headquartered in Amman, Jordan. | Specialty Stores | Founder | |
Pier Pharmaceuticals, Inc.
 Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Pier Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company which develops a pharmacologic treatment for obstructive sleep apnea (OSA). It develops Dronabinol a synthetic derivative of the naturally occurring substance in the cannabis plant, namely delta-9-tetrahydrocannabinol, otherwise known as delta-9 THC. The company was founded in 2007 and is headquartered in Louiseville, CO. | Medical Specialties | Chief Executive Officer | |
| ELECTROCORE, INC. | Medical Specialties | Chairman | |
| Harvard T.H. Chan School of Public Health | College/University | Corporate Officer/Principal | |
| VERASTEM, INC. | Biotechnology | Corporate Officer/Principal | |
| CANDEL THERAPEUTICS, INC. | Biotechnology | Chairman | |
| University of Pennsylvania Museum of Archaeology & Anthropolog | Corporate Officer/Principal | ||
Finch Research & Development LLC
 Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | Pharmaceuticals: Major | Chief Operating Officer | |
| FINCH THERAPEUTICS GROUP, INC. | Medical/Nursing Services | Chief Operating Officer | |
| Arabian Drug & Trading Co. | Chief Executive Officer | ||
| ORGANON & CO. | Pharmaceuticals: Major | Chairman | |
| HUMACYTE, INC. | Biotechnology | Chief Executive Officer | |
| Micromet Inc. | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 39 |
| Jordanien | 4 |
Sektoral
| Health Technology | 31 |
| Consumer Services | 4 |
| Distribution Services | 2 |
| Electronic Technology | 2 |
| Retail Trade | 2 |
Operativ
| Corporate Officer/Principal | 17 |
| Director/Board Member | 13 |
| Chairman | 11 |
| Independent Dir/Board Member | 8 |
| Undergraduate Degree | 7 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Joseph Lorello
- Unternehmensverbindungen
